"My IPSS went from 23 to 3, and I’m thoroughly satisfied with the results."1
Peter J. Walter, M.D., F.A.C.S.* Western New York Urology Associates and UROLIFT® SYSTEM PATIENT
MAIN REASONS I CHOSE THE UROLIFT® SYSTEM AND RECOMMEND IT TO MY PATIENTS:
Rapid relief and recovery in days, not months2,4
Lowest catheter rate of the leading BPH procedures4
The only BPH treatment with no new, sustained erectile or ejaculatory dysfunction2,3
The only BPH procedure that does not destroy tissue Proven durability through 5 years5
25 Peer-reviewed publications, 2 randomized studies Simple, typically, one time, in-office treatment
SHARE
The UroLift System procedure is FDA-cleared for the treatment of symptoms due to urinary outflow obstruction secondary to BPH, including lateral and median lobe hyperplasia, in men 45 years of age or older. Results and patient experience may vary. Most common adverse events reported include hematuria, dysuria, micturition urgency, pelvic pain, and urge incontinence. Most symptoms were mild to moderate in severity and resolved within 2 to 4 weeks after the procedure. Consult the Instructions for Use (IFU) for more information. *Dr. Walter is UroLift faculty and a paid consultant for NeoTract|Teleflex 1. LIFT study showed an IPSS reduction of 47% at 1 year. Roehrborn, J Urology 2013 2. Roehrbom, J Urology 2013 3. No instances of new, sustained erectile or ejaculatory dysfunction McVary, J Sex Med 2014 4. Shore, Can J Urol 2014 6. Roehrborn et al. Can J Urol 2017
